Skip to main content

Advertisement

Log in

Vitamin D induced osteopenia-A possibility?

  • Section III: Symposium II Renal Osteopathy October 30, 1992, Osaka
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Takagi, H., Tominaga, Y., Tanaka, Y., Uchida, K., Orihara, A., Yamada, N., Kawai, M., Hayashi, S., Taira, N., Kano, T.: Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann. Surg. 208: 639–644, 1988

    CAS  PubMed  Google Scholar 

  2. Felsenfeld, A.J., Harrelson, J.M., Gutman, R.A., Wells, S.A. Jr, Drezner, M.K.: Osteomalacia after parathyroidectomy in patients with uremia. Ann. Intern. Med. 96: 34–39, 1982

    CAS  PubMed  Google Scholar 

  3. Andress, D.L., Ott, S.M., Maloney, N.A., Sherrard, D.J.: Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N. Engl. J. Med. 312: 468–473, 1985

    CAS  PubMed  Google Scholar 

  4. Norris, K.C., Crooks, P.W., Nebeker, H.G., Hercz, G., Milliner, D.S., Gerszi, K., Slatopolsky E., Andress, D.L., Sherrard, D.J., Coburn, J.W.: Clinical and laboratory features of aluminum-related bone disease: Differences between sporadic and “epidemic” forms of the syndrome. Am. J. Kid. Dis. 6: 342–347, 1985

    CAS  PubMed  Google Scholar 

  5. Berland, Y., Charhon, S., Olmer, M., Meunier, P.: Changes following parathyroidectomy in hemodialyzed patients. Miner Electr Metab. 9: 176–177, 1983

    Google Scholar 

  6. Cohen Solal ME, Sebert JL, Boudailliez B, Garabedian M, A. Non aluminic adynamic bone disease in non dialyzed uremic patients. A new type of osteopathy due to overtreatment? Bone 13(1): 1–5, 1992

    CAS  PubMed  Google Scholar 

  7. Fournier A, Moriniere P, Cohen Solal ME, Boudailliez JM, Achard JM, Marie A, Sebert JL. Adynamic bone disease in uremia: May it be idiopathic? Is it an actual disease? Nephron 58: 1–12, 1991

    CAS  PubMed  Google Scholar 

  8. Lieberherr, M., Grosse, B., Cournot-Witmer, G., Hermann-Erlee, M.P.M., Balsan, S.: Aluminum action on mouse bone cell metabolism and response to PTH and 1,25 (OH)2D3. Kidney Int. 31: 736–743, 1987

    CAS  PubMed  Google Scholar 

  9. Vukicevic, S., Stavljenic, A: Aluminum accumulates on inactive bone surfaces after parathyroidectomy in uremic rats. Horm. Metabol. Res. 21: 15–17, 1989

    CAS  Google Scholar 

  10. Effects of aluminum on the parathyroid hormone receptors of bone and kidney. Kidney Int., 37: 72–78, 1990

  11. Hercz G, Peri Y, Manuel A, Saiphoo C, Goodman WG, Segre GV, Sherrard DJ. Aplastic osteodystrophy without aluminum in dialysis patients (abstract) Kidney Int. 37: 449, 1990

    Google Scholar 

  12. Dunlay, R., Rodriguez, M., Felsenfeld, A., Llach, F.: Parathyroid function in aplastic bone disease without aluminum overload (abstract). Kidney Int. 37: 294, 1900

    Google Scholar 

  13. Andress, D.L., Sherrard, D.J.: The osteodystrophy of chronic renal failure. In: Diseases of the kidney, eds. Schrier, R.W., Gottschalk, C.W, Boston, Little, Brown and Co., pp2759–2788, 1992

    Google Scholar 

  14. Malluche, H.H., Faugere, M-.C.: Effects of 1,25(OH)2D3 administration on bone in patients with renal failure. Kidney Int. 38: S-48–S-53, 1990

    Google Scholar 

  15. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J: Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30: 57–62, 1988

    CAS  PubMed  Google Scholar 

  16. Torres, A., Lorenzo, V., Gonzalez-Posada, J.M.: Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy. Nephron 44: 282–287, 1986

    CAS  PubMed  Google Scholar 

  17. Malluche, H.H., Faugere, M-.C.: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int. 193–211, 1990

  18. Ito M, Hayashi K, Ito M: Veterbral density distribution pattern: CT classification of patients undergoing maintenance hemodialysis. Radiology 180: 253–257, 1991

    CAS  PubMed  Google Scholar 

  19. Rasmussen JN, Mosekilde L: Local differences in mineral content in vertebral trabecular bone measured by dual-energy computed tomography. Acta Radiol 30: 369–371, 1989

    Google Scholar 

  20. Marumo F, Sakurai K, Sato N, Shimada H, Iwanami S, Uchida H. Influence of long-term hemodialysis on bone mineral content as estimated by computed tomography. In: Nose Y, Kjellstrand C and Ivanovich P, eds. Progress in Artificial Organs, Cleveland, ISAO Press: 192–196, 1986

    Google Scholar 

  21. Sakurai K, Marumo F, Iwanami S, Uchida H, Matsubayashi T. Quantitative computed tomographic evaluation of femoral bone mineral content in renal osteodystrophy compared with radial photon absorptiometry. Invest Radiol 24: 375–382, 1989

    CAS  PubMed  Google Scholar 

  22. Baker, L.R.I., Abrams, S.M.L., Roe, C.J., Faugere, M-.C., Fanti, P., Subayti, Y., Malluche, H.H.: 1,25(OH)2D3 administration in moderate renal failure: A prospective duble-blind trial. Kidney Int. 35: 661–669, 1989

    CAS  PubMed  Google Scholar 

  23. Tsukamoto Y, Nomura Y, Marumo F: Pharmacological parathyroidectomy by oral 1,25(OH)2D2 pulse therapy. Nephron 51: 130–131, 1989

    CAS  PubMed  Google Scholar 

  24. Tsukamoto Y, Nomura Y, Takahashi Takagi Y, Yoshida A, Nagaoka T, Togashi K,: Kikawada R, Marumo F: The ‘oral 1,25-dihydroxyvitamin D3 pulse therapy’ in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 57: 23–28, 1991

    CAS  PubMed  Google Scholar 

  25. Moriya, R., Tsukamoto, Y., Nomura, Y., Sato, N., Sakurai, K.: Relatively high PTH level is required to maintain bone formation in hemodialyzed uremic patients: Effect of PTH on bone mineral content. Bone Miner 17(suppl. 1): 208, 1992

    Google Scholar 

  26. Hodsman, A.B., Wong, E.G.C., Sherrard, D.J., Brickman, A.S., Lee, D.B.NM., Singer, F.R., Norman, A.W., Coburn, J.W.: Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia. Am. J. Med. 74: 407–414, 1983

    Article  CAS  PubMed  Google Scholar 

  27. Dunstan, C.R., Hills, E., Norman, A.W., Bishop, J.E., Mayer, E., Wong, S.Y.P., Eade, Y., Johnson, J.R., George, C.R.P., Collett, P., Kalowski, S. Wyndham, R.N., Lawrence, J.R., Alfrey, A.C., Evans, R.A.: Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Miner Electr Metab 11: 358–368, 1985

    CAS  Google Scholar 

  28. Moscovici, A., Rubinger, D., Popovtzer, M.M.: Long-term effect of combined 1,25(OH)2D3 and 24,25(OH)2D3 therapy on uremic osteodystrophy. J. Amer. Soc. Nephrol. 2: 613, 1991 (abstract)

    Google Scholar 

  29. Birkenhager-Frenkel, D.H., Pols, H.A.P., Nigg, A.L., Clermonts, E., Birkenhager, J.C.: 24,25-dihydroxyvitamin D3 appears to favour cortical bone mass in renal disease. Bone Miner 17 (suppl. 1): 114, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Tsukamoto, Y. Vitamin D induced osteopenia-A possibility?. J Bone Miner Metab 11, S71–S74 (1993). https://doi.org/10.1007/BF02383846

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02383846

Keywords

Navigation